CFDE Data Portal | Search PKD1P4

	Label	Description
	PKD1P4 Gene (Entity type)	ENSG00000205746 - polycystin 1, transient receptor potential channel interacting pseudogene 4
	GSE195663 cisplatin 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE80098 GSE80366 progesterone 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE149632 dopamine 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE145960 GSE145962 bms 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128255 NDP knockdown stem cell 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 7 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

PKD1P4

ENSG00000205746 - polycystin 1, transient receptor potential channel interacting pseudogene 4

GSE195663 cisplatin 0 v 3 human up

A Gene Set from LINCS

GSE113655 phenol 1 v 2 human dn

A Gene Set from LINCS

GSE77108 saha 4 v 7 human up

A Gene Set from LINCS

GSE80098 GSE80366 progesterone 0 v 5 human dn

A Gene Set from LINCS

GSE149632 dopamine 0 v 6 human up

A Gene Set from LINCS

GSE261563 CX-5461 3 v 1 human dn

A Gene Set from LINCS

GSE145960 GSE145962 bms 3 v 1 human dn

A Gene Set from LINCS

GSE128255 NDP knockdown stem cell 3 v 0 human up

A Gene Set from LINCS

GSE195663 cisplatin 7 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.